Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-ornithine-L-aspartate in Minimal Hepatic Encephalopathy
NCT00896831Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Nov 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-ornithine l-aspartate in hepatic encephalopathy (HE), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT00896831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896831.